4
Changes in Ownership
SUTRO BIOPHARMA, INC. Filed Acc 0001415889-25-023083
Chief Executive Officer gave up 6,708 shares (to pay taxes)
- Chief Executive Officer acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chung Jane Chief Executive Officer | 2025-08-09 | Option exercise | +18,750 | 117,058 | D | ||
| Chung Jane Chief Executive Officer | 2025-08-09 | Shares withheld for taxes | −6,708 | $0.80 | $5,366 | 110,350 | D |
| Derivatives | |||||||
| Chung Jane Chief Executive Officer | 2025-08-09 | Option exercise · Restricted Stock Unit (RSU) | −18,750 | 0 | D | ||
Loading xslF345X05/form4-08272025_010839.xml…